Saliva test upstart Rako Science sold to rival APHG

Saliva test upstart Rako Science sold to rival APHG
Rako Science partnered with Waipareira Trust to provide covid saliva testing for Māori. (Image: NZME)
Pattrick Smellie
Today’s announcement of the sale of saliva-testing firm Rako Science to what was once its arch-rival, Asia Pacific Healthcare Group (APHG), is a classic case of the old adage: “If you can’t beat 'em, join 'em”.For more than a year at the height of the covid lockdowns, Rako and APHG were at one another’s throats both in public and behind-the-scenes as Rako aggressively pressed the case for national uptake of its novel saliva test technology.Rako’s main target was the health ministry, which appeared to...

More Opinion

When the fast-track isn’t the best track
Policy

Sarah Mitchell: When the fast-track isn’t the best track

Key considerations for businesses and the Fast-Track Approvals Act.

Sarah Mitchell 17 Mar 2025
Trump, trade, and NZ’s next move
Opinion

Dileepa Fonseka: Trump, trade, and NZ’s next move

US power is not predictable nor reliable, but what does this mean for New Zealand?

Dileepa Fonseka 17 Mar 2025
Transparency: the biz case for shining a light
Opinion

Simon Robertson: Transparency: the biz case for shining a light

US Supreme Court jurist highlighted the value of publicity in fighting corruption.

Simon Robertson 15 Mar 2025
'Boom, bap, boom': A rating downgrade roll
Opinion

Cameron Bagrie: 'Boom, bap, boom': A rating downgrade roll

A margin of excellence rating downgrade could dent NZD sentiment.

Cameron Bagrie 13 Mar 2025